Brito-da-Costa Andreia Machado, Dias-da-Silva Diana, Gomes Nelson G M, Dinis-Oliveira Ricardo Jorge, Madureira-Carvalho Áurea
Department of Sciences, IINFACTS-Institute of Research and Advanced Training in Health Sciences and Technologies, University Institute of Health Sciences (IUCS), CESPU, CRL, 4585-116 Gandra, Portugal.
UCIBIO-REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Pharmaceuticals (Basel). 2020 Oct 23;13(11):334. doi: 10.3390/ph13110334.
Ayahuasca is a hallucinogenic botanical beverage originally used by indigenous Amazonian tribes in religious ceremonies and therapeutic practices. While ethnobotanical surveys still indicate its spiritual and medicinal uses, consumption of ayahuasca has been progressively related with a recreational purpose, particularly in Western societies. The ayahuasca aqueous concoction is typically prepared from the leaves of the ,-dimethyltryptamine (DMT)-containing , and the stem and bark of , the plant source of harmala alkaloids. Herein, the toxicokinetics and toxicodynamics of the psychoactive DMT and harmala alkaloids harmine, harmaline and tetrahydroharmine, are comprehensively covered, particularly emphasizing the psychological, physiological, and toxic effects deriving from their concomitant intake. Potential therapeutic utility, particularly in mental and psychiatric disorders, and forensic aspects of DMT and ayahuasca are also reviewed and discussed. Following administration of ayahuasca, DMT is rapidly absorbed and distributed. Harmala alkaloids act as potent inhibitors of monoamine oxidase A (MAO-A), preventing extensive first-pass degradation of DMT into 3-indole-acetic acid (3-IAA), and enabling sufficient amounts of DMT to reach the brain. DMT has affinity for a variety of serotonergic and non-serotonergic receptors, though its psychotropic effects are mainly related with the activation of serotonin receptors type 2A (5-HT). Mildly to rarely severe psychedelic adverse effects are reported for ayahuasca or its alkaloids individually, but abuse does not lead to dependence or tolerance. For a long time, the evidence has pointed to potential psychotherapeutic benefits in the treatment of depression, anxiety, and substance abuse disorders; and although misuse of ayahuasca has been diverting attention away from such clinical potential, research onto its therapeutic effects has now strongly resurged.
阿亚瓦斯卡是一种致幻植物性饮料,最初被亚马逊地区的土著部落用于宗教仪式和治疗实践。虽然民族植物学调查仍表明其具有精神和药用价值,但阿亚瓦斯卡的消费已逐渐与娱乐目的相关联,尤其是在西方社会。阿亚瓦斯卡的水性混合物通常由含有N,N-二甲基色胺(DMT)的植物的叶子,以及骆驼蓬生物碱的植物来源的茎和树皮制备而成。本文全面涵盖了精神活性物质DMT和骆驼蓬生物碱(如去甲骆驼蓬碱、骆驼蓬灵和四氢骆驼蓬碱)的毒代动力学和毒效动力学,特别强调了它们同时摄入所产生的心理、生理和毒性作用。还对DMT和阿亚瓦斯卡的潜在治疗效用,特别是在精神和精神疾病方面,以及法医方面进行了综述和讨论。服用阿亚瓦斯卡后,DMT会迅速被吸收和分布。骆驼蓬生物碱是单胺氧化酶A(MAO-A)的强效抑制剂,可防止DMT大量首过代谢为3-吲哚乙酸(3-IAA),并使足够量的DMT到达大脑。DMT对多种血清素能和非血清素能受体具有亲和力,但其精神作用主要与2A 型血清素受体(5-HT)的激活有关。单独使用阿亚瓦斯卡或其生物碱时,报告的轻度至极少严重的迷幻不良反应,但滥用不会导致依赖或耐受性。长期以来,有证据表明其在治疗抑郁症、焦虑症和物质滥用障碍方面具有潜在的心理治疗益处;尽管阿亚瓦斯卡的滥用转移了人们对其临床潜力的关注,但目前对其治疗效果的研究已强烈复苏。